127 related articles for article (PubMed ID: 12018852)
1. Hypertonicity induction of melanoma antigen, a tumor-associated antigen.
Park JH; Lee SW
Mol Cells; 2002 Apr; 13(2):288-95. PubMed ID: 12018852
[TBL] [Abstract][Full Text] [Related]
2. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
[TBL] [Abstract][Full Text] [Related]
3. Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.
Krishnadas DK; Bao L; Bai F; Chencheri SC; Lucas K
Tumour Biol; 2014 Jun; 35(6):5753-62. PubMed ID: 24584817
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
5. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
Cruz CR; Gerdemann U; Leen AM; Shafer JA; Ku S; Tzou B; Horton TM; Sheehan A; Copeland A; Younes A; Rooney CM; Heslop HE; Bollard CM
Clin Cancer Res; 2011 Nov; 17(22):7058-66. PubMed ID: 21908573
[TBL] [Abstract][Full Text] [Related]
6. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
8. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
9. Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.
Gunda V; Cogdill AP; Bernasconi MJ; Wargo JA; Parangi S
Surgery; 2013 Dec; 154(6):1456-62; discussion 1462. PubMed ID: 24238058
[TBL] [Abstract][Full Text] [Related]
10. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.
Chen PW; Murray TG; Uno T; Salgaller ML; Reddy R; Ksander BR
Clin Exp Metastasis; 1997 Sep; 15(5):509-18. PubMed ID: 9247253
[TBL] [Abstract][Full Text] [Related]
11. Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine.
Shichijo S; Yamada A; Sagawa K; Iwamoto O; Sakata M; Nagai K; Itoh K
Jpn J Cancer Res; 1996 Jul; 87(7):751-6. PubMed ID: 8698626
[TBL] [Abstract][Full Text] [Related]
12. Induction of MAGE-3 expression in lung and esophageal cancer cells.
Weiser TS; Ohnmacht GA; Guo ZS; Fischette MR; Chen GA; Hong JA; Nguyen DM; Schrump DS
Ann Thorac Surg; 2001 Jan; 71(1):295-301; discussion 301-2. PubMed ID: 11216765
[TBL] [Abstract][Full Text] [Related]
13. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
[TBL] [Abstract][Full Text] [Related]
14. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
Karpf AR; Lasek AW; Ririe TO; Hanks AN; Grossman D; Jones DA
Mol Pharmacol; 2004 Jan; 65(1):18-27. PubMed ID: 14722233
[TBL] [Abstract][Full Text] [Related]
15. Expression of MAGE genes in human colorectal carcinoma.
Mori M; Inoue H; Mimori K; Shibuta K; Baba K; Nakashima H; Haraguchi M; Tsuji K; Ueo H; Barnard GF; Akiyoshi T
Ann Surg; 1996 Aug; 224(2):183-8. PubMed ID: 8757382
[TBL] [Abstract][Full Text] [Related]
16. Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.
Goodyear O; Agathanggelou A; Novitzky-Basso I; Siddique S; McSkeane T; Ryan G; Vyas P; Cavenagh J; Stankovic T; Moss P; Craddock C
Blood; 2010 Sep; 116(11):1908-18. PubMed ID: 20530795
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
Mol Cell Biol; 1999 Nov; 19(11):7327-35. PubMed ID: 10523621
[TBL] [Abstract][Full Text] [Related]
18. MAGE: the spell is broken.
Rezvani K
Clin Cancer Res; 2011 Nov; 17(22):6955-7. PubMed ID: 22068655
[TBL] [Abstract][Full Text] [Related]
19. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
20. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
